Streamlining Cell Line Development | Strategies for Emerging Biotech Start-Ups

Sartorius is excited to host an in-person event on Thursday, May 26, in Cambridge, UK. Designed for biotech start-ups developing biologics, the event will highlight the advantages and disadvantages of various approaches of cell line development (CLD) and the impact early decision-making can have at later stages of biologics development. Industry leaders from Abzena, AstraZeneca, GSK will share their experiences and best practices in developing robust, stable, high-yielding cell lines.

Join us for an evening of networking and to gain insights on:

• Modern cell line development workflows and their critical steps.
• Various approaches to CLD and their advantages and disadvantages.
• Key points to consider when evaluating external providers of CLD products and services.